A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

1. Martin, M.
2. Bonneterre, J.
3. Geyer Jr., C.E.
4. Ito, Y.
5. Ro, J.
6. Lang, I.
7. Kim, S.-B.
8. Germa, C.
9. Vermette, J.
10. Wang, K.
11. Wang, K.
12. Awada, A.